Hair Restore MDT Scalp Solution

$119.00

A clinical-grade triple-combination scalp solution for androgenic alopecia in men and women: Minoxidil, Dutasteride, and Tretinoin (MDT). Each ingredient addresses hair loss through a different mechanism — vasodilation, DHT blockade, and penetration enhancement — creating a synergistic effect superior to any single agent alone. Compounded by a licensed 503A pharmacy based on your clinician's prescription.

Active ingredients and their roles

  • Minoxidil — prolongs the hair growth phase and increases follicle size via scalp vasodilation
  • Dutasteride — inhibits both Type 1 and Type 2 5-alpha reductase, blocking DHT more completely than finasteride
  • Tretinoin — enhances minoxidil penetration and supports follicle activity

What it may help with

  • Androgenic alopecia (male and female pattern hair loss)
  • Diffuse thinning and hairline recession
  • Increased hair density and reduced shedding over 3–6 months of consistent use

Dutasteride is teratogenic — confirm reproductive status before prescribing. Requires testosterone, DHT, and PSA labs for male patients. Clinician evaluation required. Prescription required.

A clinical-grade triple-combination scalp solution for androgenic alopecia in men and women: Minoxidil, Dutasteride, and Tretinoin (MDT). Each ingredient addresses hair loss through a different mechanism — vasodilation, DHT blockade, and penetration enhancement — creating a synergistic effect superior to any single agent alone. Compounded by a licensed 503A pharmacy based on your clinician's prescription.

Active ingredients and their roles

  • Minoxidil — prolongs the hair growth phase and increases follicle size via scalp vasodilation
  • Dutasteride — inhibits both Type 1 and Type 2 5-alpha reductase, blocking DHT more completely than finasteride
  • Tretinoin — enhances minoxidil penetration and supports follicle activity

What it may help with

  • Androgenic alopecia (male and female pattern hair loss)
  • Diffuse thinning and hairline recession
  • Increased hair density and reduced shedding over 3–6 months of consistent use

Dutasteride is teratogenic — confirm reproductive status before prescribing. Requires testosterone, DHT, and PSA labs for male patients. Clinician evaluation required. Prescription required.